NASDAQ:KIDS

OrthoPediatrics (KIDS) Stock Price, News & Analysis

$30.20
-0.11 (-0.36%)
(As of 04/22/2024 ET)
Today's Range
$29.51
$30.75
50-Day Range
$24.99
$31.77
52-Week Range
$23.10
$53.50
Volume
127,432 shs
Average Volume
184,784 shs
Market Capitalization
$718.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$42.50

OrthoPediatrics MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
40.7% Upside
$42.50 Price Target
Short Interest
Bearish
6.55% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.20
Upright™ Environmental Score
News Sentiment
0.33mentions of OrthoPediatrics in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$477,375 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.34) to ($1.32) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.91 out of 5 stars

Medical Sector

160th out of 909 stocks

Surgical & Medical Instruments Industry

24th out of 97 stocks

KIDS stock logo

About OrthoPediatrics Stock (NASDAQ:KIDS)

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

KIDS Stock Price History

KIDS Stock News Headlines

Incredible Opportunity to Retire FAST!
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
The Analyst Verdict: OrthoPediatrics In The Eyes Of 6 Experts
Incredible Opportunity to Retire FAST!
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
KIDS Apr 2024 40.000 put
OrthoPediatrics: Q4 Earnings Snapshot
Recap: OrthoPediatrics Q4 Earnings
Best Mattresses for Kids in 2024
OrthoPediatrics just downgraded at Truist, here's why
Decoding 5 Analyst Evaluations For OrthoPediatrics
See More Headlines
Receive KIDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/06/2024
Today
4/23/2024
Next Earnings (Estimated)
5/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:KIDS
Employees
247
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$42.50
High Stock Price Target
$52.00
Low Stock Price Target
$31.00
Potential Upside/Downside
+40.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-20,970,000.00
Pretax Margin
-14.33%

Debt

Sales & Book Value

Annual Sales
$148.73 million
Book Value
$16.14 per share

Miscellaneous

Free Float
16,222,000
Market Cap
$718.46 million
Optionable
Optionable
Beta
1.16
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives


KIDS Stock Analysis - Frequently Asked Questions

Should I buy or sell OrthoPediatrics stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrthoPediatrics in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" KIDS shares.
View KIDS analyst ratings
or view top-rated stocks.

What is OrthoPediatrics' stock price target for 2024?

4 Wall Street analysts have issued 1-year price objectives for OrthoPediatrics' shares. Their KIDS share price targets range from $31.00 to $52.00. On average, they predict the company's stock price to reach $42.50 in the next year. This suggests a possible upside of 40.7% from the stock's current price.
View analysts price targets for KIDS
or view top-rated stocks among Wall Street analysts.

How have KIDS shares performed in 2024?

OrthoPediatrics' stock was trading at $32.51 at the start of the year. Since then, KIDS stock has decreased by 7.1% and is now trading at $30.20.
View the best growth stocks for 2024 here
.

Are investors shorting OrthoPediatrics?

OrthoPediatrics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 1,040,000 shares, an increase of 10.5% from the March 15th total of 941,200 shares. Based on an average trading volume of 179,900 shares, the short-interest ratio is currently 5.8 days. Approximately 6.6% of the shares of the company are sold short.
View OrthoPediatrics' Short Interest
.

When is OrthoPediatrics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our KIDS earnings forecast
.

How were OrthoPediatrics' earnings last quarter?

OrthoPediatrics Corp. (NASDAQ:KIDS) released its earnings results on Wednesday, March, 6th. The company reported ($0.23) EPS for the quarter, topping the consensus estimate of ($0.28) by $0.05. The business earned $37.61 million during the quarter, compared to the consensus estimate of $37.59 million. OrthoPediatrics had a negative trailing twelve-month return on equity of 5.03% and a negative net margin of 14.10%.

What guidance has OrthoPediatrics issued on next quarter's earnings?

OrthoPediatrics issued an update on its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $197.0 million-$200.0 million, compared to the consensus revenue estimate of $182.9 million.

What is Mark Throdahl's approval rating as OrthoPediatrics' CEO?

15 employees have rated OrthoPediatrics Chief Executive Officer Mark Throdahl on Glassdoor.com. Mark Throdahl has an approval rating of 100% among the company's employees. This puts Mark Throdahl in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of OrthoPediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrthoPediatrics investors own include AbbVie (ABBV), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Intel (INTC), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Cisco Systems (CSCO), Walt Disney (DIS), Enterprise Products Partners (EPD) and NVIDIA (NVDA).

When did OrthoPediatrics IPO?

OrthoPediatrics (KIDS) raised $52 million in an initial public offering on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.

Who are OrthoPediatrics' major shareholders?

OrthoPediatrics' stock is owned by a number of retail and institutional investors. Top institutional investors include Wasatch Advisors LP (2.11%). Insiders that own company stock include (Reynolds) Marie C Infante, Bernie B Berry III, Bernie B Berry III, Daniel J Gerritzen, David R Bailey, Fred Hite, Gregory A Odle, Harold Ruf, Jennifer N Pritzker, Joseph W Hauser, Mark C Throdahl, Stephen F Burns and Terry D Schlotterback.
View institutional ownership trends
.

How do I buy shares of OrthoPediatrics?

Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:KIDS) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners